HuGE Literature Finder
Records
1
-
30
| Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases. The oncologist 2021 Jun . Huang Richard S P, Haberberger James, McGregor Kimberly, Mata Douglas A, Decker Brennan, Hiemenz Matthew C, Lechpammer Mirna, Danziger Natalie, Schiavone Kelsie, Creeden James, Graf Ryon P, Strowd Roy, Lesser Glenn J, Razis Evangelia D, Bartsch Rupert, Giannoudis Athina, Bhogal Talvinder, Lin Nancy U, Pusztai Lajos, Ross Jeffrey S, Palmieri Carlo, Ramkissoon Shakti |
| Single nucleotide polymorphisms in breast cancer susceptibility gene 1 are associated with susceptibility to lung cancer. Oncology letters 2021 May 21 (5): 424. Liu Dan, Gao Ya, Li Lingling, Chen He, Bai Lu, Qu Yanli, Zhou Baosen, Yan Ying, Zhao Yux |
| Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study. European journal of breast health 2021 Apr 17 (2): 123-127. Atci Muhammed Mustafa, Geredeli Çaglayan, Ay Seval, Sakin Abdullah, Ertürk Biray, Seçmeler Saban, Arici Serdar, Çekin Ruhper, Yasar Nurgül, Can Orçun, Cihan Sener, Gümüs Mahm |
| Homologous recombination repair gene mutations show no survival benefits in Chinese high-grade serous ovarian cancer patients. Annals of translational medicine 2021 Mar 9 (5): 364. Feng Zheng, Wen Hao, Ju Xingzhu, Bi Rui, Chen Xiaojun, Yang Wentao, Wu Xiaoh |
| Mutational spectrum in clinically aggressive low-grade serous carcinoma/serous borderline tumors of the ovary-Clinical significance of BRCA2 gene variants in genomically stable tumors. Gynecologic oncology 2021 Mar . Zhang Xiaoming, Devins Kyle, Ko Emily M, Reyes Maria Carolina, Simpkins Fiona, Drapkin Ronny, Schwartz Lauren E, Yoon Ju-Yo |
| Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder. Signal transduction and targeted therapy 2021 Feb 6 (1): 55. Liu Fatao, Li Yongsheng, Ying Dongjian, Qiu Shimei, He Yong, Li Maolan, Liu Yun, Zhang Yijian, Zhu Qin, Hu Yunping, Liu Liguo, Li Guoqiang, Pan Weihua, Jin Wei, Mu Jiasheng, Cao Yang, Liu Yingb |
| Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2021 Jan . Lotan Tamara L, Kaur Harsimar B, Salles Daniela C, Murali Sanjana, Schaeffer Edward M, Lanchbury Jerry S, Isaacs William B, Brown Robert, Richardson Andrea L, Cussenot Olivier, Cancel-Tassin Geraldine, Timms Kirsten M, Antonarakis Emmanuel |
| BRCA2 3'-UTR Polymorphism rs15869 Alters Susceptibility to Papillary Thyroid Carcinoma via Binding hsa-mir-1178-3p. Pharmacogenomics and personalized medicine 2021 14 533-544. Guo Nan, Qu Peng, Li Hao, Liu Liuli, Jin Hao, Liu Renqi, Zhang Zhen, Zhang Xuan, Li Yingchun, Lu Xiaobo, Zhao Yueji |
| Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations. Gynecologic oncology 2020 Dec . Ghezelayagh Talayeh S, Pennington Kathryn P, Norquist Barbara M, Khasnavis Nithisha, Radke Marc R, Kilgore Mark R, Garcia Rochelle L, Lee Ming, Katz Ronit, Leslie Kimberly K, Risques Rosa Ana, Swisher Elizabeth |
| Prevalence and spectrum of pathogenic germline variants in intestinal and pancreatobiliary type of ampullary cancer. Pathology, research and practice 2020 Dec 217 153309. Kumari Niraj, Singh Rajneesh K, Mishra Shravan K, L Raghvendra, Mohindra Samir, Krishnani Narend |
| Impact of BRCA1/2 Mutations on the Efficacy of Secondary Cytoreductive Surgery. Annals of surgical oncology 2020 Nov . Estati Felipe Leonardo, Pirolli Rafaela, de Alencar Viviane Teixeira Loiola, Ribeiro Adriana Regina Gonçalves, Formiga Maria Nirvana, Torrezan Giovana Tardin, Carraro Dirce Maria, Guimarães Andrea Paiva Gadelha, Baiocchi Glauco, da Costa Alexandre André Balieiro Anastác |
| BRCA testing in women with high-grade serous ovarian cancer: gynecologic oncologist-initiated testing compared with genetics referral. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020 (11): 1757-1761. Piedimonte Sabrina, Power Joanne, Foulkes William D, Weber Evan, Palma Laura, Schiavi Alicia, Ambrosio Enza, Konci Rea, Gilbert Lucy, Jardon Kris, Baret Laurence, Zeng Xi |
| Clinical implications of next-generation sequencing-based panel tests for malignant ovarian tumors. Cancer medicine 2020 Aug . Saotome Keiko, Chiyoda Tatsuyuki, Aimono Eriko, Nakamura Kohei, Tanishima Shigeki, Nohara Sachio, Okada Chihiro, Hayashi Hideyuki, Kuroda Yuka, Nomura Hiroyuki, Susumu Nobuyuki, Iwata Takashi, Yamagami Wataru, Kataoka Fumio, Nishihara Hiroshi, Aoki Daisu |
| Pathogenic germline variants in patients with features of hereditary renal cell carcinoma: Evidence for further locus heterogeneity. Genes, chromosomes & cancer 2020 Aug . Smith Philip S, West Hannah, Whitworth James, Castle Bruce, Sansbury Francis H, Warren Anne Y, Woodward Emma R, Tischkowitz Marc, Maher Eamonn |
| Prevalence of Tissue BRCA Gene Mutation in Ovarian, Fallopian Tube, and Primary Peritoneal Cancers: A Multi-Institutional Study. Asian Pacific journal of cancer prevention : APJCP 2020 Aug 21 (8): 2381-2388. Lertkhachonsuk Arb-Aroon, Suprasert Prapaporn, Manchana Tarinee, Kittisiam Thannaporn, Kantathavorn Nuttavut, Chansoon Tharintorn, Khunamornpong Surapan, Pohthipornthawat Natkrita, Tangjitgamol Siriwan, Luasiripanthu Taksa, Teerapakpinyo Chinachote, Shuangshot Shanop, Iemwimangsa Nareenart, Chantratita Was |
| Recurrent BRCA1 Mutation, but no BRCA2 Mutation, in Vietnamese Patients with Ovarian Carcinoma Detected with Next Generation Sequencing. Asian Pacific journal of cancer prevention : APJCP 2020 Aug 21 (8): 2331-2335. Vu Hoang Anh, Phu Ngo Dai, Khuong Le Thai, Hoa Pham Huy, Nhu Bui Thi Hong, Nhan Vo Thanh, Thanh Le Quang, Sinh Nguyen Duy, Chi Hoang Thanh, Quan Nguyen Dang, Binh Nguyen Tro |
| Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy. Cirugia espanola 2020 Jun . Allué Cabañuz Marta, Domingo Bretón María, Chóliz Ezquerro Jorge, Arribas Del Amo María Dolores, Güemes Sánchez Antonio Tom |
| Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes. Nature communications 2020 Apr 11 (1): 1640. Subramanian Deepak N, Zethoven Magnus, McInerny Simone, Morgan James A, Rowley Simone M, Lee Jue Er Amanda, Li Na, Gorringe Kylie L, James Paul A, Campbell Ian |
| Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings. Cancer 2020 Feb . Maynard Hannah, Stadler Zsofia K, Berger Michael F, Solit David B, Ly Michele, Lowery Maeve A, Mandelker Diana, Zhang Liying, Jordan Emmett, El Dika Imane, Kemel Yelena, Ladanyi Marc, Robson Mark E, O'Reilly Eileen M, Abou-Alfa Ghassan |
| Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma. Cancer research and treatment : official journal of Korean Cancer Association 2020 Jan . Choi Min Chul, Hwang Sohyun, Kim Sewha, Jung Sang Geun, Park Hyun, Joo Won Duk, Song Seung Hun, Lee Chan, Kim Tae-Heon, Kang Haeyoun, An Hee Ju |
| BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA. Journal of hepatology 2019 Dec . Hirsch Théo Z, Negulescu Ana, Gupta Barkha, Caruso Stefano, Noblet Bénédicte, Couchy Gabrielle, Bayard Quentin, Meunier Léa, Morcrette Guillaume, Scoazec Jean-Yves, Blanc Jean-Frédéric, Amaddeo Giuliana, Nault Jean-Charles, Bioulac-Sage Paulette, Ziol Marianne, Beaufrère Aurélie, Paradis Valérie, Calderaro Julien, Imbeaud Sandrine, Zucman-Rossi Jessi |
| Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Dec . Nassar Amin H, Abou Alaiwi Sarah, AlDubayan Saud H, Moore Nicholas, Mouw Kent W, Kwiatkowski David J, Choueiri Toni K, Curran Catherine, Berchuck Jacob E, Harshman Lauren C, Nuzzo Pier V, Chanza Nieves Martinez, Van Allen Eliezer, Esplin Edward D, Yang Shan, Callis Thomas, Garber Judy E, Rana Huma Q, Sonpavde Gu |
| Rare BRIP1 Missense Alleles Confer Risk for Ovarian and Breast Cancer. Cancer research 2019 Dec . Moyer Cassandra L, Ivanovich Jennifer, Gillespie Jessica L, Doberstein Rachel, Radke Marc R, Richardson Marcy E, Kaufmann Scott H, Swisher Elizabeth M, Goodfellow Paul |
| Germline mutations in Thai patients with nonmucinous epithelial ovarian cancer. World journal of clinical oncology 2019 Nov 10 (11): 358-368. Manchana Tarinee, Phowthongkum Prasit, Teerapakpinyo Chinacho |
| Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients. Cancer genetics 2019 Oct 240 23-32. Cecener Gulsah, Takanlou Leila Sabour, Takanlou Maryam Sabour, Egeli Unal, Eskiler Gamze Guney, Aksoy Secil, Unal Ufuk, Tezcan Havva, Eryilmaz Isil Ezgi, Gokgoz Mustafa Sehsuvar, Tunca Berrin, Cubukcu Erdem, Evrensel Turkkan, Cetintas Sibel, Tasdelen Ism |
| Germline mutations in cancer-predisposition genes in patients with biliary tract cancer. Oncotarget 2019 Oct 10 (57): 5949-5957. Terashima Takeshi, Umemoto Kumiko, Takahashi Hideaki, Hosoi Hiroko, Takai Erina, Kondo Shunsuke, Sakamoto Yasunari, Mitsunaga Shuichi, Ohno Izumi, Hashimoto Yusuke, Sasaki Mitsuhito, Ikeda Masafumi, Shimada Kazuaki, Kaneko Shuichi, Yachida Shinichi, Sugano Kokichi, Okusaka Takuji, Morizane Chigu |
| Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 Jul 28 (7): 1162-1168. Petridis Christos, Arora Iteeka, Shah Vandna, Moss Charlotte L, Mera Anca, Clifford Angela, Gillett Cheryl, Pinder Sarah E, Tomlinson Ian, Roylance Rebecca, Simpson Michael A, Sawyer Elinor |
| Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50?years. Breast cancer research : BCR 2019 May 21 (1): 58. Petridis Christos, Arora Iteeka, Shah Vandna, Megalios Anargyros, Moss Charlotte, Mera Anca, Clifford Angela, Gillett Cheryl, Pinder Sarah E, Tomlinson Ian, Roylance Rebecca, Simpson Michael A, Sawyer Elinor |
| Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data. Gynecologic oncology 2019 May . Cohen Paul A, Powell Aime, Böhm Steffen, Gilks C Blake, Stewart Colin J R, Meniawy Tarek M, Bulsara Max, Avril Stefanie, Brockbank Eleanor C, Bosse Tjalling, de Azevedo Focchi Gustavo Rubino, Ganesan Raji, Glasspool Rosalind M, Howitt Brooke E, Kim Hyun-Soo, Lee Jung-Yun, Le Nhu D, Lockley Michelle, Manchanda Ranjit, Mandalia Trupti, McCluggage W Glenn, McNeish Iain, Midha Divya, Srinivasan Radhika, Tan Yun Yi, van der Griend Rachael, Yunokawa Mayu, Zannoni Gian F, , Singh Navee |
| Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study. World journal of urology 2019 Feb . Aydin Ahmet M, Singla Nirmish, Panwar Vandana, Woldu Solomon L, Freifeld Yuval, Wood Christopher G, Karam Jose A, Weizer Alon Z, Raman Jay D, Remzi Mesut, Rioux-Leclercq Nathalie, Haitel Andrea, Roscigno Marco, Bolenz Christian, Bensalah Karim, Westerman Mary E, Sagalowsky Arthur I, Shariat Shahrokh F, Lotan Yair, Bagrodia Aditya, Kapur Payal, Margulis Vitaly, Krabbe Laura-Mar |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: